Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Lianhe Chemical Technology Co., Ltd. (002250.SZ)
CNY16.26
+1.17 (+7.75%)
CN SHZ Basic Materials Chemicals - Specialty
Address
8 Yongjiao Road 318020
Taizhou, CN
Taizhou, CN
CEO
Ping Wang
Website
lianhetech.com
IPO
2008-06-06
ISIN CNE100000C15
Description
Operating from its base in Taizhou, China, Lianhe Chemical Technology Co., Ltd. is a company established in 1985 that engages in the development, production, commercialization, and sale of chemical goods across China. Its extensive product range encompasses crop protection solutions, specialized industrial chemicals, and pharmaceutical ingredients. Furthermore, the company extends its services to include engineering solutions and the fabrication of necessary equipment.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY16.26
+1.17 (+7.75%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
17M
Beta
0.67
Float Shares
628.75M
Free Float %
69.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.86% | -2.33% | -13.69% | -24.36% | +12.65% | +6.50% | +70.45% | +30.14% | -43.99% | +8.04% | +653.97% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
16.26
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.24
Grey zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%+13.3% ★ Q1'26: +30.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+263.6% ★ Q1'26: +101.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.1% ★ Q1'26: -11.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+9.2% ★ Q1'26: +13.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+6.4% ★ Q1'26: +7.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-2.9% ★ Q1'26: -1.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.23× Q1'26: 4.16× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.01B
est: 4.16B (-3.7%)
|
3.10B
est: 3.46B (-10.5%)
|
4.11B
est: 3.93B (+4.6%)
|
4.11B
est: 4.16B (-1.1%)
|
4.28B
est: 4.31B (-0.5%)
|
4.78B
est: 4.71B (+1.5%)
|
6.59B
est: 6.02B (+9.5%)
|
7.87B
est: 7.91B (-0.5%)
|
6.44B
est: 8.55B (-24.6%)
|
5.68B
est: 6.68B (-15.0%)
|
6.43B
est: 6.31B (+1.9%)
|
7.91B
7.91B – 7.91B
+25.3% YoY
|
9.34B
9.34B – 9.34B
+18.1% YoY
|
9.93B
9.93B – 9.93B
+6.4% YoY
|
| EBITDA |
992.79M
est: 725.23M (+36.9%)
|
610.06M
est: 603.28M (+1.1%)
|
665.88M
est: 684.17M (-2.7%)
|
659.06M
est: 724.88M (-9.1%)
|
1.01B
est: 749.99M (+35.2%)
|
1.03B
est: 821.04M (+25.4%)
|
1.15B
est: 1.05B (+9.5%)
|
1.35B
est: 1.38B (-2.4%)
|
731.20M
est: 1.49B (-50.9%)
|
1.12B
est: 1.18B (-5.4%)
|
1.47B
est: 1.12B (+31.8%)
|
1.40B
1.40B – 1.40B
+25.3% YoY
|
1.65B
1.65B – 1.65B
+18.1% YoY
|
1.76B
1.76B – 1.76B
+6.4% YoY
|
| EBIT |
740.63M
est: 297.72M (+148.8%)
|
293.06M
est: 247.66M (+18.3%)
|
292.68M
est: 280.87M (+4.2%)
|
247.66M
est: 297.58M (-16.8%)
|
567.16M
est: 307.89M (+84.2%)
|
549.36M
est: 337.06M (+63.0%)
|
582.03M
est: 430.17M (+35.3%)
|
758.33M
est: 565.55M (+34.1%)
|
-35.94M
est: 611.11M (-105.9%)
|
360.48M
est: 447.38M (-19.4%)
|
592.00M
est: 422.47M (+40.1%)
|
529.35M
529.35M – 529.35M
+25.3% YoY
|
625.22M
625.22M – 625.22M
+18.1% YoY
|
664.98M
664.98M – 664.98M
+6.4% YoY
|
| Net Income |
638.07M
est: 737.85M (-13.5%)
|
263.85M
est: 456.42M (-42.2%)
|
204.53M
est: 243.78M (-16.1%)
|
37.53M
est: 37.51M (+0.1%)
|
144.25M
est: 187.34M (-23.0%)
|
110.03M
est: 223.16M (-50.7%)
|
315.41M
est: 300.04M (+5.1%)
|
696.84M
est: 707.91M (-1.6%)
|
-465.24M
est: 721.97M (-164.4%)
|
103.14M
est: 109.24M (-5.6%)
|
361.94M
est: 405.09M (-10.7%)
|
616.74M
616.74M – 616.74M
+52.2% YoY
|
769.22M
769.22M – 769.22M
+24.7% YoY
|
1.03B
1.03B – 1.03B
+34.3% YoY
|
| SGA |
724.85M
est: 518.79M (+39.7%)
|
684.29M
est: 431.56M (+58.6%)
|
602.83M
est: 489.42M (+23.2%)
|
636.81M
est: 518.54M (+22.8%)
|
830.51M
est: 536.51M (+54.8%)
|
800.41M
est: 587.33M (+36.3%)
|
730.15M
est: 749.59M (-2.6%)
|
769.68M
est: 985.49M (-21.9%)
|
785.98M
est: 1.06B (-26.2%)
|
709.59M
est: 642.42M (+10.5%)
|
160.71M
est: 606.65M (-73.5%)
|
760.12M
760.12M – 760.12M
+25.3% YoY
|
897.79M
897.79M – 897.79M
+18.1% YoY
|
954.87M
954.87M – 954.87M
+6.4% YoY
|
| EPS |
0.77
est: 0.79 (-2.2%)
|
0.32
est: 0.49 (-34.3%)
|
0.22
est: 0.26 (-15.4%)
|
0.04
est: 0.04 (+0.0%)
|
0.16
est: 0.20 (-19.9%)
|
0.12
est: 0.24 (-49.6%)
|
0.34
est: 0.32 (+6.3%)
|
0.75
est: 0.76 (0.0%)
|
-0.50
est: 0.77 (-164.9%)
|
0.11
est: 0.12 (-8.3%)
|
0.40
est: 0.45 (-10.1%)
|
0.68
0.68 – 0.68
+52.2% YoY
|
0.85
0.85 – 0.85
+24.7% YoY
|
1.14
1.14 – 1.14
+34.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.88B
OE per share TTM
2.08
Owner's Yield
14.64%
Maintenance CapEx ratio
337.51%
Maint CapEx / Avg PPE
110.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 20 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.02% | 150.2K | 0.65% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 431.3K | 0.39% |
| 3 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 75.8K | 0.46% |
| 4 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 466.7K | 0.06% |
| 5 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 12.2K | 0.44% |
| 6 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 146.4K | 0.29% |
| 7 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 166.3K | 0.28% |
| 8 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 34.9K | 0.26% |
| 9 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 15.5K | 0.48% |
| 10 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.72M | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
102.6K
Shares Outstanding
899.87M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chun He | Senior Vice President of Functional Chemicals Division & Non-Executive Director | — | male |
| Fei Biao Chen | Senior Vice President & Secretary of The Board of Directors | — | male |
| Ping Wang | Chairman & Chief Executive Officer | — | female |
| Xiao Bin Fan | Senior Vice President of Pesticides Division & Director | — | male |
| Yun Xuan Xue | Financial Director & Accounting Supervisor | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002250.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
